- Home
- ODD vs CNTA Comparison
ODD vs CNTA Comparison
Compare ODD & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODD
- CNTA
- Stock Information
- Founded
- ODD 2018
- CNTA 2020
- Country
- ODD Israel
- CNTA United Kingdom
- Employees
- ODD N/A
- CNTA N/A
- Industry
- ODD
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- ODD
- CNTA Health Care
- Exchange
- ODD Nasdaq
- CNTA Nasdaq
- Market Cap
- ODD 2.3B
- CNTA 1.8B
- IPO Year
- ODD 2023
- CNTA 2021
- Fundamental
- Price
- ODD $71.00
- CNTA $12.30
- Analyst Decision
- ODD Buy
- CNTA Strong Buy
- Analyst Count
- ODD 8
- CNTA 10
- Target Price
- ODD $54.63
- CNTA $26.11
- AVG Volume (30 Days)
- ODD 1.1M
- CNTA 617.5K
- Earning Date
- ODD 04-29-2025
- CNTA 05-20-2025
- Dividend Yield
- ODD N/A
- CNTA N/A
- EPS Growth
- ODD 45.36
- CNTA N/A
- EPS
- ODD 1.74
- CNTA N/A
- Revenue
- ODD $703,488,000.00
- CNTA N/A
- Revenue This Year
- ODD $22.39
- CNTA N/A
- Revenue Next Year
- ODD $20.09
- CNTA N/A
- P/E Ratio
- ODD $40.82
- CNTA N/A
- Revenue Growth
- ODD 26.83
- CNTA N/A
- 52 Week Low
- ODD $32.71
- CNTA $7.75
- 52 Week High
- ODD $69.96
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- ODD 84.66
- CNTA 40.97
- Support Level
- ODD $39.55
- CNTA $11.88
- Resistance Level
- ODD $43.14
- CNTA $14.39
- Average True Range (ATR)
- ODD 3.73
- CNTA 0.79
- MACD
- ODD 2.35
- CNTA -0.00
- Stochastic Oscillator
- ODD 99.78
- CNTA 18.68
About ODD ODDITY Tech Ltd.
ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.